January 24, 2023 -- Harvard University researchers and collaborators conducted a modeling study that showed tuberculosis (TB) vaccination could be cost-effective in 73 of 105 (70%) low- and middle-income countries. The results, published on January 24 in PLOS Medicine, also predicted $474 billion in vaccine-related benefits by 2050.

Ahmedabad: A mobile application is helping bridge the gap in knowledge regarding tuberculosis for thousands of healthcare workers as the Central government strives to achieve its ambitious target to reduce the TB burden by 2025.

Decentralised molecular testing for TB could reduce missed diagnoses and losses to follow-up in high-burden settings.

Overview

The Stop TB Partnership and partners will host a webinar on 26 January 2023, What's new in childhood TB.

The bacillus Calmette-Guérin vaccine against tuberculosis—or simply BCG—is the oldest vaccine in the world that is still currently in use. Millions of infants in Africa and Asia receive the inoculation each year.

The World Bank's Board of Executive Directors has approved a $300 million loan to the Indonesian government to improve coverage, quality and efficiency of tuberculosis (TB) response in Indonesia.

Pulmonary hypertension (PH) is estimated to be highly prevalent among people with a history of tuberculosis (TB) who successfully completed treatment, a study in South Africa reports.

Tuberculosis is an infectious disease of the lungs that’s been with humanity for centuries and affects a quarter of the world’s population. The stubborn disease killed over a million and a half people in 2021, mostly in lower- and middle- income countries where access to basic resources is scarce.

The Council will facilitate the licensing and use of effective novel TB vaccines catalysing high-level alignment between funders, global agencies, governments and end users in identifying and overcoming barriers to TB vaccine development.